CISPLATIN NEPHROTOXICITY
Clinical trials for CISPLATIN NEPHROTOXICITY explained in plain language.
Never miss a new study
Get alerted when new CISPLATIN NEPHROTOXICITY trials appear
Sign up with your email to follow new studies for CISPLATIN NEPHROTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Diabetes drug may shield kidneys from chemo damage
Disease control Recruiting nowThis study tests whether dapagliflozin, a drug used for diabetes, can prevent kidney damage caused by platinum-based chemotherapy in people with solid tumors. About 46 participants will receive either dapagliflozin or a placebo, and researchers will measure urine markers of kidne…
Matched conditions: CISPLATIN NEPHROTOXICITY
Phase: PHASE2 • Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Simple supplement may shield kidneys from chemo harm
Symptom relief Recruiting nowThis study tests whether alpha-lipoic acid, a natural antioxidant, can prevent kidney damage in cancer patients receiving cisplatin chemotherapy. About 50 adults with solid tumors will take either alpha-lipoic acid or a placebo alongside their chemo. Researchers will monitor kidn…
Matched conditions: CISPLATIN NEPHROTOXICITY
Phase: PHASE2 • Sponsor: Minia University • Aim: Symptom relief
Last updated May 13, 2026 16:01 UTC